A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

NCT05459532 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Witwatersrand, South Africa

Collaborators